639 related articles for article (PubMed ID: 14720012)
1. Prostanoids for pulmonary arterial hypertension.
Galiè N; Manes A; Branzi A
Am J Respir Med; 2003; 2(2):123-37. PubMed ID: 14720012
[TBL] [Abstract][Full Text] [Related]
2. Prostanoid therapy for pulmonary arterial hypertension.
Badesch DB; McLaughlin VV; Delcroix M; Vizza CD; Olschewski H; Sitbon O; Barst RJ
J Am Coll Cardiol; 2004 Jun; 43(12 Suppl S):56S-61S. PubMed ID: 15194179
[TBL] [Abstract][Full Text] [Related]
3. [Role of prostacyclin and its derivatives in the treatment of pulmonary arterial hypertension].
Osvaldo Cáneva J; Ossés JM
Medicina (B Aires); 2003; 63(3):233-6. PubMed ID: 12876911
[TBL] [Abstract][Full Text] [Related]
4. Clinical value of prostacyclin and its analogs in the management of pulmonary arterial hypertension.
Dandel M; Hetzer R
Curr Vasc Pharmacol; 2003 Jun; 1(2):171-81. PubMed ID: 15320842
[TBL] [Abstract][Full Text] [Related]
5. Overview of treprostinil sodium for the treatment of pulmonary arterial hypertension.
Budev MM; Minai OA; Arroliga AC
Drugs Today (Barc); 2004 Mar; 40(3):225-34. PubMed ID: 15148531
[TBL] [Abstract][Full Text] [Related]
6. Effects of beraprost sodium, an oral prostacyclin analogue, in patients with pulmonary arterial hypertension: a randomized, double-blind, placebo-controlled trial.
Galiè N; Humbert M; Vachiéry JL; Vizza CD; Kneussl M; Manes A; Sitbon O; Torbicki A; Delcroix M; Naeije R; Hoeper M; Chaouat A; Morand S; Besse B; Simonneau G;
J Am Coll Cardiol; 2002 May; 39(9):1496-502. PubMed ID: 11985913
[TBL] [Abstract][Full Text] [Related]
7. The role of treprostinil in the management of pulmonary hypertension.
Skoro-Sajer N; Lang I
Am J Cardiovasc Drugs; 2008; 8(4):213-7. PubMed ID: 18690755
[TBL] [Abstract][Full Text] [Related]
8. Efficacy of long-term subcutaneous treprostinil sodium therapy in pulmonary hypertension.
Lang I; Gomez-Sanchez M; Kneussl M; Naeije R; Escribano P; Skoro-Sajer N; Vachiery JL
Chest; 2006 Jun; 129(6):1636-43. PubMed ID: 16778286
[TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy of transition from systemic prostanoids to inhaled treprostinil in pulmonary arterial hypertension.
de Jesus Perez VA; Rosenzweig E; Rubin LJ; Poch D; Bajwa A; Park M; Jain M; Bourge RC; Kudelko K; Spiekerkoetter E; Liu J; Hsi A; Zamanian RT
Am J Cardiol; 2012 Nov; 110(10):1546-50. PubMed ID: 22853986
[TBL] [Abstract][Full Text] [Related]
10. Beraprost therapy for pulmonary arterial hypertension.
Barst RJ; McGoon M; McLaughlin V; Tapson V; Rich S; Rubin L; Wasserman K; Oudiz R; Shapiro S; Robbins IM; Channick R; Badesch D; Rayburn BK; Flinchbaugh R; Sigman J; Arneson C; Jeffs R;
J Am Coll Cardiol; 2003 Jun; 41(12):2119-25. PubMed ID: 12821234
[TBL] [Abstract][Full Text] [Related]
11. Cost effectiveness of prostacyclins in pulmonary arterial hypertension.
Roman A; Barberà JA; Escribano P; Sala ML; Febrer L; Oyagüez I; Sabater E; Casado MA
Appl Health Econ Health Policy; 2012 May; 10(3):175-88. PubMed ID: 22452448
[TBL] [Abstract][Full Text] [Related]
12. How has epoprostenol changed the outcome for patients with pulmonary arterial hypertension?
Barst R
Int J Clin Pract Suppl; 2010 Nov; (168):23-32. PubMed ID: 20939843
[TBL] [Abstract][Full Text] [Related]
13. Pulmonary arterial hypertension: new insights into the optimal role of current and emerging prostacyclin therapies.
Waxman AB; Zamanian RT
Am J Cardiol; 2013 Mar; 111(5 Suppl):1A-16A; quiz 17A-19A. PubMed ID: 23414683
[TBL] [Abstract][Full Text] [Related]
14. Addition of inhaled treprostinil to oral therapy for pulmonary arterial hypertension: a randomized controlled clinical trial.
McLaughlin VV; Benza RL; Rubin LJ; Channick RN; Voswinckel R; Tapson VF; Robbins IM; Olschewski H; Rubenfire M; Seeger W
J Am Coll Cardiol; 2010 May; 55(18):1915-22. PubMed ID: 20430262
[TBL] [Abstract][Full Text] [Related]
15. Comparative Safety and Tolerability of Prostacyclins in Pulmonary Hypertension.
O'Connell C; Amar D; Boucly A; Savale L; Jaïs X; Chaumais MC; Montani D; Humbert M; Simonneau G; Sitbon O
Drug Saf; 2016 Apr; 39(4):287-94. PubMed ID: 26748508
[TBL] [Abstract][Full Text] [Related]
16. Prostacyclin for pulmonary hypertension in adults.
Paramothayan NS; Lasserson TJ; Wells AU; Walters EH
Cochrane Database Syst Rev; 2005 Apr; 2005(2):CD002994. PubMed ID: 15846646
[TBL] [Abstract][Full Text] [Related]
17. Inhaled prostanoids in the therapy of pulmonary hypertension.
Gessler T; Seeger W; Schmehl T
J Aerosol Med Pulm Drug Deliv; 2008 Mar; 21(1):1-12. PubMed ID: 18518827
[TBL] [Abstract][Full Text] [Related]
18. [Long-term experience with trerpostinil infusion treatment in patients with pulmonary arterial hypertension in the Czech Republic].
Jansa P; Ambroz D; Maresová J; Jelínková L; Polácek P; Palecek T; Aschermann M; Linhart A
Vnitr Lek; 2007 Apr; 53(4):333-7. PubMed ID: 17578162
[TBL] [Abstract][Full Text] [Related]
19. Prostacyclin for pulmonary hypertension.
Paramothayan NS; Lasserson TJ; Wells AU; Walters EH
Cochrane Database Syst Rev; 2003; (2):CD002994. PubMed ID: 12804447
[TBL] [Abstract][Full Text] [Related]
20. Treprostinil for pulmonary hypertension.
Skoro-Sajer N; Lang I; Naeije R
Vasc Health Risk Manag; 2008; 4(3):507-13. PubMed ID: 18827901
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]